How likely are you to consider a patient's antibiotic prescription history when assessing their risk of stroke or secondary stroke?
Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
1 Mar, 24Source
26 Mar, 24
This Indian study demonstrated telmisartan to be efficacious and tolerable for BP control in Indian hypertension patients when used as monotherapy or in combination therapy. The benefits of telmisartan were independent of age, duration, and stages of hypertension.
30 Apr, 24J Orthop Surg Res.
New research has suggested that preoperative grip strength could be a valuable predictor for postoperative shoulder function in patients undergoing arthroscopic rotator cuff repair (ARCR). Higher baseline grip strength correlated with better postoperative shoulder function. Conversely, an increased number of total suture anchors and higher body mass index were associated with poorer postoperative outcomes.
29 Apr, 24Int J Gen Med.
In a study involving over 200,000 adults aged 55 and older with acute ischemic stroke (AIS) or acute hemorrhagic stroke (AHS), pre-antibiotic use within a year before the stroke event was linked to increased risks of secondary stroke in both groups (aHR of 1.03, p = 0.009 for AIS and 1.08, p < 0.001 for AHS). However, pre-antibiotic use in the AIS group was tied to a reduced risk of mortality (aHR 0.95, p < 0.001).
Pulse Check0
29 Apr, 24Cureus.
- From 21 studies included in analysis,15.2% of the isolates were pandrug-resistant P. aeruginosa (PDR-PA. PDR-PA was largely hospital-acquired. Patients suffering from burn injuries and chronic lung diseases had a higher risk of colonization than other hospitalized individuals
- Administration of colistin was preferred therapeutic in five studies
- Acinetobacter and Klebsiella sp. occurred most frequently with PDR...
29 Apr, 24Diabetologia.
- As per the analysis of 12 studies (n=1248), CGM (both real-time & intermittent) reduced HbA1c by 0.31% vs SMBG in T2DM patients
- CGM improved time in target glucose range (+6.36%) & decreased time below range (-0.66%), time above range (-5.56%), & glycemic variability (-1.47%)
- Limited data showed an insignificant increase in severe hypoglycemia & microvascular complications with CGM vs SMBG
Featured
19 Apr, 23
24 Apr, 23
13 Jan, 22